The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-((R)-2-amino-2-oxo-1-phenylethyl)-2-(2,2-diphenylacetamido)-5-guanidinopentanamide ID: ALA4776204
PubChem CID: 102509168
Max Phase: Preclinical
Molecular Formula: C28H32N6O3
Molecular Weight: 500.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](C(N)=O)c1ccccc1
Standard InChI: InChI=1S/C28H32N6O3/c29-25(35)24(21-15-8-3-9-16-21)34-26(36)22(17-10-18-32-28(30)31)33-27(37)23(19-11-4-1-5-12-19)20-13-6-2-7-14-20/h1-9,11-16,22-24H,10,17-18H2,(H2,29,35)(H,33,37)(H,34,36)(H4,30,31,32)/t22-,24-/m1/s1
Standard InChI Key: VREKBHVPVINEDT-ISKFKSNPSA-N
Molfile:
RDKit 2D
37 39 0 0 0 0 0 0 0 0999 V2000
7.2545 -11.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1125 -11.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8270 -11.0500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5414 -11.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2559 -11.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9703 -11.4625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2559 -10.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5414 -12.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3980 -11.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1125 -12.2875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3980 -10.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6836 -11.4625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9691 -11.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9691 -10.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1125 -9.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1125 -8.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8270 -8.5749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8270 -7.7499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5414 -7.3374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1125 -7.3374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8247 -12.6983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8244 -13.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5394 -13.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2563 -13.5189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2530 -12.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5401 -11.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2545 -12.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5455 -10.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8319 -9.8114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1164 -10.2240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1191 -11.0533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8333 -11.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5376 -12.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5373 -13.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2522 -13.9353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9691 -13.5183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9659 -12.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 2 0
4 8 1 1
2 9 1 0
2 10 2 0
9 11 1 6
9 12 1 0
12 13 1 0
13 1 1 0
13 14 2 0
11 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
8 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 8 1 0
1 26 1 0
1 27 1 0
26 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 26 1 0
27 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 500.60Molecular Weight (Monoisotopic): 500.2536AlogP: 1.91#Rotatable Bonds: 12Polar Surface Area: 163.19Molecular Species: BASEHBA: 4HBD: 6#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 8#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.05CX Basic pKa: 11.67CX LogP: 1.51CX LogD: -0.55Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.13Np Likeness Score: -0.27
References 1. Nguyen T,Marusich J,Li JX,Zhang Y. (2020) Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development., 63 (21.0): [PMID:32673481 ] [10.1021/acs.jmedchem.0c00643 ] 2. Quillet R, Schneider S, Utard V, Drieu la Rochelle A, Elhabazi K, Henningsen JB, Gizzi P, Schmitt M, Kugler V, Simonneaux V, Ilien B, Simonin F, Bihel F.. (2021) Identification of an N -acylated-D Arg-Leu-NH2 Dipeptide as a Highly Selective Neuropeptide FF1 Receptor Antagonist That Potently Prevents Opioid-Induced Hyperalgesia., 64 (11.0): [PMID:34008968 ] [10.1021/acs.jmedchem.1c00256 ]